Assessing Striatal Dopamine in Schizophrenia

Carol A. Tamminga

doi:10.1016/j.biopsych.2021.11.001

Assessing Striatal Dopamine in Schizophrenia

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	170-172
Number of pages	3
Journal	Biological Psychiatry
Volume	91
Issue number	2
DOIs	https://doi.org/10.1016/j.biopsych.2021.11.001
State	Published - Jan 15 2022

ASJC Scopus subject areas

Biological Psychiatry

Access to Document

10.1016/j.biopsych.2021.11.001

Cite this

@article{8f105fdd182b4e4db5c7bf43ac834c12,

title = "Assessing Striatal Dopamine in Schizophrenia",

author = "Tamminga, {Carol A.}",

note = "Funding Information: CAT has received National Institutes of Mental Health Grant Nos. MH124813, MH112815, 705977 (Simons Foundation Funding), MH096890, and MH123479. CAT is employed at UT Southwestern Medical School and by the National Institutes of Mental Health for membership on a Study Section and occasional ad hoc committees. She has been a consultant for Sunovion, Astellas, and Merck; is a member of a Merck DSMB; and is a scientific board member with Kynexis Inc and Karuna, owning Karuna stock. Funding Information: CAT has received National Institutes of Mental Health Grant Nos. MH124813 , MH112815 , 705977 ( Simons Foundation Funding), MH096890 , and MH123479 . ",

year = "2022",

month = jan,

day = "15",

doi = "10.1016/j.biopsych.2021.11.001",

language = "English (US)",

volume = "91",

pages = "170--172",

journal = "Biological Psychiatry",

issn = "0006-3223",

publisher = "Elsevier USA",

number = "2",

}

TY - JOUR

T1 - Assessing Striatal Dopamine in Schizophrenia

AU - Tamminga, Carol A.

N1 - Funding Information: CAT has received National Institutes of Mental Health Grant Nos. MH124813, MH112815, 705977 (Simons Foundation Funding), MH096890, and MH123479. CAT is employed at UT Southwestern Medical School and by the National Institutes of Mental Health for membership on a Study Section and occasional ad hoc committees. She has been a consultant for Sunovion, Astellas, and Merck; is a member of a Merck DSMB; and is a scientific board member with Kynexis Inc and Karuna, owning Karuna stock. Funding Information: CAT has received National Institutes of Mental Health Grant Nos. MH124813 , MH112815 , 705977 ( Simons Foundation Funding), MH096890 , and MH123479 .

PY - 2022/1/15

Y1 - 2022/1/15

UR - http://www.scopus.com/inward/record.url?scp=85122512453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122512453&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2021.11.001

DO - 10.1016/j.biopsych.2021.11.001

M3 - Comment/debate

C2 - 34916029

AN - SCOPUS:85122512453

VL - 91

SP - 170

EP - 172

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 2

ER -

Assessing Striatal Dopamine in Schizophrenia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this